• Z-IETD-FMK: Caspase-8 Inhibitor for Targeted Apoptosis Resea

  2026-06-04

  Z-IETD-FMK (Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone) is a high-specificity, irreversible caspase-8 inhibitor. It blocks apoptosis initiation and modulates T cell proliferation without affecting resting cell viability, with benchmarked efficacy in immune and cancer research models. This article synthesizes core evidence, protocol guidance, and practical limitations for optimal experimental use.

• Cyclosporin A: Deep Mechanistic Insights for Neuroimmune Res

  2026-06-04

  Explore Cyclosporin A's advanced mechanisms in immunosuppression and mitochondrial modulation, with emphasis on novel neuroimmune assay strategies. This article offers a unique, evidence-driven perspective for researchers using Cyclosporin in cutting-edge experimental designs.

• Bismuth Subsalicylate (A8382): Mechanisms & GI Research Use

  2026-06-03

  Bismuth Subsalicylate, also known as 1,3,2λ2-benzodioxabismin-4-one, is a high-purity, water-insoluble compound widely used in gastrointestinal disorder research. Its primary mechanism involves inhibition of prostaglandin G/H synthase 1/2, conferring anti-inflammatory and gut-protective effects. This dossier details its biological rationale, evidence benchmarks, workflow parameters, and common misconceptions, emphasizing rigorous, verifiable facts.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-06-03

  This study demonstrates that naturally occurring angiotensin peptides, including Angiotensin 1/2 (1-6), can significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings highlight a novel mechanistic link between the renin-angiotensin system and viral pathogenesis, with implications for both cardiovascular research and COVID-19 studies.

• Homoharringtonine Rapidly Clears SARS-CoV-2: Study Advances

  2026-06-02

  A recent study demonstrates that homoharringtonine, a cytotoxic alkaloid, can rapidly eliminate SARS-CoV-2 from the upper respiratory tract in animal models and early-phase clinical settings. These findings position it as a promising candidate for future coronavirus outbreak preparedness, with mechanistic relevance spanning both antiviral and cancer biology research.

• Valemetostat: Transforming EZH2 Mutant Inhibition in Lymphom

  2026-06-02

  Valemetostat (DS-3201) redefines epigenetic cancer research, offering potent, selective inhibition of EZH2—including mutant variants—while supporting advanced immunotherapy strategies. This article delivers actionable protocols, troubleshooting insights, and a direct bridge from breakthrough reference findings to translational workflows.

• Practical Use of Omeprazole (A2845) in Gastric Acid Research

  2026-06-01

  Omeprazole (SKU A2845) is a high-purity H+,K+-ATPase inhibitor for precise control of gastric acid secretion in laboratory models. This product is best suited for mechanistic studies of antiulcer activity and gastric acid-related disorders, not for diagnostic or therapeutic use. Careful adherence to solubility, storage, and assay boundaries is required for reproducible results.

• Berberrubine Chloride: Translational Leverage in Cancer & Me

  2026-06-01

  This article provides translational researchers with an advanced, mechanistic and strategic perspective on Berberrubine chloride (9-hydroxy-10-methoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride). We synthesize recent mechanistic data, experimental workflows, and clinical potential, referencing both peer-reviewed evidence and APExBIO’s protocol-driven product intelligence. Researchers will find actionable guidance and a nuanced comparison to emerging antifungal and anti-cancer agents.

• Tacrolimus (FK506): Precision Tools for T-Cell Assay Reliabi

  2026-05-31

  This article presents scenario-driven, evidence-based insights into the use of Tacrolimus (FK506) (SKU B2143) for advanced cell viability, proliferation, and cytokine signaling assays. Drawing on validated performance data and real laboratory challenges, it outlines how Tacrolimus (FK506) ensures reproducibility, high sensitivity, and workflow integrity for biomedical researchers.

• E-4031: hERG Potassium Channel Blocker for 3D Cardiac Resear

  2026-05-30

  E-4031 is a benchmark hERG potassium channel blocker enabling precise modeling of proarrhythmic substrates and QT prolongation, especially in advanced 3D cardiac organoid systems. This article details applied workflows, optimization strategies, and troubleshooting tips to leverage E-4031’s nanomolar potency for cutting-edge electrophysiology studies.

• Topotecan in First-Line SCLC: Implications for Topoisomerase

  2026-05-29

  This article examines the reference study's evaluation of topotecan as a first-line therapy for small cell lung cancer (SCLC), highlighting its efficacy, toxicity profile, and mechanistic innovation as a topoisomerase I inhibitor. The findings inform broader research on DNA damage and apoptosis induction, with practical implications for preclinical models using related compounds such as Irinotecan (CPT-11).

• XXLP Modulates NOX2/ROS/Mitochondria/NLRP3 Axis in Ulcerativ

  2026-05-29

  Xu Chunfu’s Modified Xianglian Pill (XXLP) demonstrates efficacy in alleviating ulcerative colitis by regulating the NOX2/ROS/mitochondria/NLRP3 axis and modulating gut microbiota composition. This study provides mechanistic and translational insights into how traditional Chinese medicine can target redox and inflammatory pathways in colitis models.

• Luminescent ATP Detection Assay Kit: Precision in Cellular E

  2026-05-28

  Unlock ultra-sensitive cellular ATP quantification with the firefly luciferase-based Luminescent ATP Detection Assay Kit. Streamline your metabolic research with robust, reproducible workflows compatible with downstream proteomics and challenging sample types.

• KR-12 Human Antimicrobial Peptide: Applied Protocols & Innov

  2026-05-28

  KR-12, the smallest active human antimicrobial peptide, combines potent anti-biofilm and LPS-neutralizing functions with minimal cytotoxicity, enabling targeted research on multidrug-resistant pathogens and inflammatory models. This article delivers actionable workflows, protocol guidance, and troubleshooting strategies for maximizing KR-12’s impact in translational antimicrobial and immunomodulatory research.

• Luminescent ATP Detection Assay Kit: Precision ATP Quantific

  2026-05-27

  The Luminescent ATP Detection Assay Kit enables sensitive, reproducible cellular ATP quantification using firefly luciferase catalysis. Its broad linear range, streamlined sample preparation, and stable signal facilitate robust energy metabolism analysis in diverse biological samples.

16155 records 1/1077 page Next 12345 下5页 Last page